For example, high activation of interleukin-6/IL-6 receptor signal transducer and STAT3 signaling pathway was observed in the gastric cancer cells MGC803 and BGC823 treated with CIS in comparison to untreated cells, triggering a CIS-induced CSC-like enrichment. Here, STAT3 is linked to in situ carcinoma.